ResMed Inc
ResMed Inc. develops and sells medical devices, masks, accessories, and cloud-based software used to diagnose, treat, and manage respiratory disorders. Its business spans sleep apnea and other breathing conditions, with operations and customers across the United States, Canada, Latin America, Europe, Asia, and other international markets.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueDevices used to diagnose and treat sleep-disordered breathing and other respiratory conditions.
Mask systems, headgear, and related accessories used with therapy devices.
Software-as-a-service tools for out-of-hospital care providers and care coordination.
Customers
ResMed sells to healthcare providers, durable medical equipment channels, homecare providers, and other organizations that diagnose or manage chronic respiratory disease. It also serves out-of-hospital care providers through its residential care software business, which supports patient management and care workflows. End users are typically patients with sleep apnea, COPD, neuromuscular disease, and related chronic conditions.
Clinics, physicians, and care channels that buy devices and masks for sleep apnea and respiratory therapy.
Providers that distribute therapy devices and consumables to patients for home use.
Facilities that use ventilation devices, masks, and related respiratory products.
Senior living, long-term care, home health, and hospice operators using SaaS workflow tools.
Strategy
ResMed’s strategy centers on expanding connected care across sleep and respiratory disease through devices, masks, and cloud software. It also invests in product development, digital features, and software platforms that help providers manage patients outside the hospital and create recurring customer relationships.
Integrated devices and software improve patient outcomes and provider workflow.
Software adds recurring revenue and deepens relationships with care providers.
International reach diversifies demand and supports scale in devices and consumables.
Geography
ResMed reports revenue across two broad regions: U.S., Canada and Latin America, and Combined Europe, Asia and other markets. In the latest quarter, U.S., Canada and Latin America accounted for $835.0 million of revenue, while Combined Europe, Asia and other markets contributed $420.9 million. The company’s mix reflects a global installed base for devices and recurring demand for masks, accessories, and software across home and care settings.
Risks
ResMed is exposed to demand shifts in sleep apnea and respiratory care, where adoption depends on diagnosis rates, reimbursement, and provider workflows. The business also faces supply chain, inflation, foreign exchange, and product development risks because it relies on global manufacturing, international sales, and ongoing innovation. Software and device businesses also carry cybersecurity, regulatory, and litigation exposure typical of healthcare technology companies.
International sales and software revenue are translated into U.S. dollars.
Exposure: Global operations and non-U.S. revenue
Device and mask production depends on components, logistics, and manufacturing continuity.
Medical devices and software are subject to healthcare regulation and claims risk.
Exposure: Sleep and breathing health products
Cloud-based monitoring and care software handle sensitive patient and provider data.
Exposure: Residential Care Software and connected care platforms
Higher costs can pressure pricing and operating efficiency if not offset.
Exposure: Manufacturing and distribution
Accounting
Judgemental itemsDevice, mask, and SaaS revenue may be recognized at different points in time.
Impact: Affects quarterly comparability and mix between product and software revenue
Medical devices can generate future repair or replacement costs.
Impact: Impacts cost of sales and accrued liabilities
Acquisitions and software assets require ongoing impairment assessment.
Impact: Can create non-cash charges if expected cash flows weaken
The company uses hedges to manage exposure to non-U.S. currencies.
Impact: Can affect other income/expense and balance sheet volatility
The company accrues estimates for claims and litigation when appropriate.
Impact: May affect expenses and liabilities if outcomes change
Similar listed companies
Publicly listed companies with a comparable business focus.
RemSleep Holdings Inc.
RMSL · Services-Personal Services
Viemed Healthcare, Inc
VMD · Services-Misc Health & Allied Services, NEC
AdaptHealth Corp.
AHCO · Services-Home Health Care Services
IR-Med, Inc.
Electromedical & Electrotherapeutic Apparatus
CONMED Corp
CNMD · Electromedical & Electrotherapeutic Apparatus
CONMED Corp is a U.S.-based medical technology company focused on devices and equipment used in surgical procedures.
INSMED Inc
INSM · Pharmaceutical Preparations
INSMED Inc is a U.S.-based biopharmaceutical company focused on developing and commercializing therapies for serious respiratory and other high-unmet-need diseases.
Last updated: 11/08/2026